Publication: 3718

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
      QxMD      Google Scholar   
Citation:
Oncologist vol 28 (8) 722-9
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
12
Parents:
3723  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
UG1CA189823, UG1CA190140, UG1CA232760, UG1CA233163  
Corr. Author:
 
Authors:
                               
Networks:
KS055, LAPS-AL002, LAPS-MN026, MD020, MI020, NORTHWELL, WINCORP   
Study
Alliance-A221602
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: